Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer

Genes Chromosomes and Cancer

Volumn 47, Issue 9, 2008, Pages 740-754

  Veena, Mysore S ^a   Lee, Grant ^a   Keppler, Daniel ^b   Mendonca, Marc S ^c   Redpath, J Leslie ^d   Stanbridge, Eric J ^d   Wilczynski, Sharon P ^e   Srivatsan, Eri S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TOURO UNIVERSITY CALIFORNIA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; CYSTATIN; CYSTATIN E; CYSTATIN M;

ARTICLE; BAY REGION BINDING SITE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; EXON; FEMALE; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

BASE SEQUENCE; CELL LINE, TUMOR; CYSTATINS; DNA METHYLATION; EXONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); UTERINE CERVICAL NEOPLASMS;

EID: 48249143708     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20576     Document Type: Article

References (54)

1. Abrahamson M. 1994. Cystatins. Methods Enzymol 244:685-700.
2. Ai L, Kim WJ, Kim TY, Fields CR, Massoll NA, Robertson KD, Brown KD. 2006. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Cancer Res 66:7899-78909.
3. Alvarez-Fernandez M, Barrett AJ, Gerhartz B, Dando PM, Ni J, Abrahamson M. 1999. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J Biol Chem 274:19195-19203.
4. Bachtiary B, Boutros PC, Pintilie M, Shi W, Bastianutto C, Li J, Schwock J, Zhang W, Penn LZ, Jurisica I, Fyles A, Liu F. 2006. Gene expression profiling in cervical cancer: An exploration of intratumor heterogeneity. Clin Cancer Res 12:5632-5640.
5. Barrett AJ, McDonald JK. 1986. Nomenclature: Protease, proteinase and peptidase. Biochem J 237:935.
6. Bode W, Engh R, Musil D, Thiele U, Huber R, Karshiknow A. 1988. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction cysteine proteinases. EMBO J 7:2593-2599.
7. Bosch KX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A world wide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87:796-802.
8. Bosch FX, Lorinez A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
9. Bromme D, Kaleta J. 2002. Thiol-dependent cathepsins: Pathophysiological implications and recent advances in inhibitor design. Gurr Pharm Des 8:1639-1658.
10. Chao A, Wang T, Lee Y, Hsueh S, Chao A, Chang T, Rung W, Huang S, Chao F, Wei M, Lai C. 2006. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 119:91-98.
11. Chen TM, Chen CA, Wu CC, Huang SC, Chang CF, Hsieh CY. 1994. The genotypes and prognostic significance of human papilloma viruses in cervical cancer. Int J Cancer 57:181-184.
12. Cheng Q, Lau WM, Tay SK, Chew SH, Ho TH, Hui KH. 2002. Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer 98:419-426.
13. Cheng T, Hitomi K, Van Vlijmen-Willems IM, de Jongh GJ, Yamamoto K, Nishi K, Watts C, Reinheckel T, Schalkwijk J, Zeeuwen PL. 2006. Cystatin M is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M in epidermal cornification. J Biol Chem 281:15893-15899.
14. Fujimoto T, Nishikawa A, Iwasaki M, Akuagawa N, Teramoto M, Kudo R. 2004. Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array. Gynecol Oncol 93:446-453.
15. Häckel CG, Krueger S, Grote HJ, Oshito Y, Hodges S, Johnston DA, Johnson ME, Roessner A, Ayala AG, Czerniak B. 2000. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma. Cancer 89:995-1003.
16. Haider AS, Peters SB, Kaporis H, Cardinale I, Fei J, Ott J, Blumenberg M, Bowcock AM, Krueger JG, Carucci JA. 2006. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Investig Dermatol 26:869-881.
17. Harris CP, Lu XY, Narayan G, Singh B, Murthy VVSV, Rao HR. 2003. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 36:233-241.
18. Hashimoto Y, Kondo C, Kojima T, Nagata H, Moriyama A, Hayakawa T, Katunuma N. 2006. Significance of 32-kDa cathepsin L secreted from cancer cells. Cancer Biother Radiopharm 21:217-224.
19. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heck NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, Goggins M. 2003. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 162:1151-1162.
20. Jemal A, Murray TM, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003. Cancer statistics. CA Cancer J Clin 53:5-26.
21. Jesudasan R, Rahman RA, Chandrasekharappa SC, Evans GA, Srivatsan KS. 1995. Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am J Hum Genet 56:705-715.
22. Keppler D, Solane F. 1996. Cathepsin B: Multiple enzyme forms from a single gene and their relation to cancer. Enzyme Protein 49:94-105.
23. Kim TY, Zhong S, Fields CR, Kim JH, Robertson KD. 2006. Epigenomic profiling reveals novel and frequent tatgets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancel Res 66:7490-7501.
24. Knudson AG. 1996. Hereditary cancer: Two hits revisited. J Cancer Res Clin Oncol 122:135-140.
25. Koi M, Hiroyuki M, Hideto Y, Barrett JC, Oshimura M. 1989. Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor call line SiHa. Mol Carcinog 2:12-21.
26. Kruszewski WJ, Rzepko R, Wojtacki J, Skokowski J, Kopacz A, Jaskiewicz K, Drucis K. 2004. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma. Neoplasma 51:38-43.
27. Linebaugh BE, Sameni M, Day NA, Sloane BF, Keppler D. 1999. Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem 264:100-109.
28. LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB. 2005. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11:6994-7002.
29. Makarewicz R, Drewa G, Szymansky W, Skonieczna-Makarewicz I. 1995. Cathepsin B in predicting the extent of the cervix carcinoma. Neoplasma 42:21-24.
30. Mendonca MS, Farrington DL, Mayhugh BM, Qin Y, Temples T, Comerford K, Chakrabarti R, Zainabadi K, Redpath JL, Stanbridge EJ, Srivatsan ES. 2004. Homozygous deletions within the 11q13 cervical cancer tumor suppressor locus in radiation-induced neoplastically transformed human hybrid cells. Genes Chromosomes Cancer 39:277-287.
31. Ni J, Abrahamson M, Zhang M, Fernandez MA, Grubb A, Su J, Yu GL, Li Y, Parmelee D, Xing L, Coleman TA, Gentz S, Thotakura R, Nguyen N, Hesselberg M, Gentz R. 1997. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem 272:139-146.
32. Potts W, Bowyer J, Jones H, Tucker D, Freemont AJ, Millest A, Martin C, Vernon W, Neerunjun D, Slynn G, Harper F, Maciewicz R. 2004. Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy. Int J Exp Pathol 85:85-96.
33. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. 2003. Human and mouse proteases: A comparative genomic approach. Nat Rev Genet 4:544-558.
34. Rao HP, Arias-Pulid H, Lu XY, Harris CP, Vargas H, Zhang FF, Narayan G, Schneider A, Terry MB, Murthy VVSV. 2004. Chromosomal amplification, 3q gain and eletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 4:1471-2407.
35. Roteli-Martins CM, Panetta K, Alves VA, Siqueira SA, Syrjanen KJ, Derchain SK. 1998. Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand 77:678-682.
36. Sato K, Waguri S, Ohsawa Y, Nitatori T, Kon S, Kominami E, Watanabe T, Gotow T, Uchiyama Y. 1997. Immunocytochemical localization of lysosomal cysteine and aspartic proteinases, and ubiquitin in rat epidermis. Arch Histol Cytol 60:275-287.
37. Saxon PJ, Srivatsan ES, Stanbridge EJ. 1986. Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J 5:3461-3466.
38. Schagdarsurengin U, Pfeifer GP, Dammann R. 2007. Frequent epigenetic inactivation of cystatin M in breast carcinoma. Oncogene 26:3089-3094.
39. Schuttelkopf AW, Hamilton G, Watts C, van Aalten DM. 2006. Structural basis of reduction-dependent activation of human cystatin F. J Biol Chem 28:16570-16575.
40. Sever N, Filipic M, Brzin J, Lah TT. 2002. Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro. Biol Chem 383:839-842.
41. Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Sloane BF, Keppler D. 2004. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Onocogcne 23:2206-2215.
42. Sotoripoulou G, Anicowicz A, Sager P. 1997. Identification, cloning and characterization of cystatin M, a novel cysteine proteinaase inhibitor, downregulated in breast cancer. J Biol Chem 272:903-910.
43. Srivatsan ES, Misra BC, Venugopalan M, Wilczynski SP. 1991. Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am J Hum Genet 49:868-877.
44. Srivatsan ES, Chakrabarti R, Zainabadi K, Pack SD, Benyamini P, Menonca MS, Yang PK, Kang K, Motamedi D, Sawieki MP, Zuang Z, Jesudasan RA, Bengtsson U, Sun C, Roe BA, Stanbridge KJ, Wilczynski SP, Redpath JL. 2002. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Oncogene 21:5631-5642.
45. Stabuc B, Mrevlje Z, Markovic J, Stabuc-Silih M. 2006. Expression and prognostic significance of cathepsin L in early cutaneous malignant melanoma. Neoplasma 53:259-262.
46. Stanbridge EJ, Der CJ, Doersen CJ, Nishimi RY, Peehl DM, Weissman BR, Wilkinson JE. 1982. Human cell hybrids: Analysis of transformation and tumorigenicity. Science 215:252-259.
47. Turk V, Bode W. 1991. The cystatins: Protein inhibitors of cysteine proteinases. FEBS Lett 285:213-219.
48. Vigneswaran N, Wu J, Zacharias W. 2003. Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis. Oral Oncol 39:559-568.
49. Vigneswaran N, Wu J, Sacks P, Gilcrease M, Zacharias W. 2005. Microarray gene expression profiling of cell lines from primary and metastatic tongue squamous cell carcinoma: Possible insights from emerging technology. J Oral Pathol Med 34:77-86.
50. Waguri S, Sato N, Watanabe T, Ishidoh K, Kominami E, Sato K, Uchiyama Y. 1995. Cysteine proteinases in GH4C1 cells, a rat pituitary tumor cell line, are secreted by the constitutive and regulated secretory pathways. Eur J Cell Biol 67:308-318.
51. Zainabadi K, Benyamini O, Chakrabarti R, Veena MS, Chandrasekharappa SC, Gatti RA, Srivatsan KS. 2005. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13. Genomics 85:704-714.
52. Zeeuwen PL, van Vlijmen-Willems IM, Hendriks W, Merkx GF, Schalkwijk J. 2002. A null mutation in the cystatin M/E gene of ichq mice causes juvenile lethality and defects in epidermal cornification. Hum Mol Genet 11:2867-2875.
53. Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin L, Sloane BF, Miller KR, Meschonat C, Li BD, Abreo K, Keppler D. 2004. Cystatin M: A novel candidate tumor suppressor gene for breast cancer. Cancer Res 64:6957-6964.
54. Zur Hausen H. 1997. Viruses in human cancers. Science 254:1167-1173.